Endogenous hydrogen peroxide up-regulates the expression of nitric oxide synthase in the kidney of SHR

Journal of Hypertension

Volumn 29, Issue 6, 2011, Pages 1167-1174

  Cao, Pengyu ^a   Ito, Osamu ^a   Guo, Qi ^a   Ito, Daisuke ^a   Muroya, Yoshikazu ^a   Rong, Rong ^a   Mori, Takefumi ^a   Ito, Sadayoshi ^a   Kohzuki, Masahiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

hydrogen peroxide; hypertension; kidney; NADPH oxidase; nitric oxide synthase; oxidative stress; superoxide dismutase

Indexed keywords

APOCYNIN; HYDROGEN PEROXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; UPREGULATION; WISTAR KYOTO RAT;

EID: 85027917257     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283468367     Document Type: Article

References (43)

1. Moncada S, Higgs A, Furchgott R. International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol Rev 1997; 49:137-142. (Pubitemid 27291031)
2. Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 1998; 31:1248-1254. (Pubitemid 28248823)
3. Vaziri ND, Ni Z, Oveisi F, Trnavsky-Hobbs DL. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 2000; 36:957-964.
4. Nava E, Llinas MT, Gonzalez JD, Salazar FJ. Nitric oxide synthase activity in renal cortex and medulla of normotensive and spontaneously hypertensive rats. Am J Hypertens 1996; 9:1236-1239. (Pubitemid 26423650)
5. Zhou X, Bohlen HG, Miller SJ, Unthank JL. NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo. Am J Physiol Heart Circ Physiol 2008; 295:H1008-H1016.
6. Verhagen AM, Koomans HA, Joles JA. Predisposition of spontaneously hypertensive rats to develop renal injury during nitric oxide synthase inhibition. Eur J Pharmacol 2001; 411:175-180. (Pubitemid 32013126)
7. Sunano S, Li-Bo Z, Matsuda K, Sekiguchi F, Watanabe H, Shimamura K. Endothelium-dependent relaxation by alpha 2-adrenoceptor agonists in spontaneously hypertensive rat aorta. J Cardiovasc Pharmacol 1996; 27:733-739. (Pubitemid 26134251)
8. Adler S, Huang H. Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. Am J Physiol Renal Physiol 2004; 287:F907-F913. (Pubitemid 39391087)
9. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 2003; 108:2034-2040. (Pubitemid 37337574)
10. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation 2003; 108:1253-1258. (Pubitemid 37099996)
11. Kobayashi N, DeLano FA, Schmid-Schonbein GW. Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 2005; 25:2114-2121. (Pubitemid 41416309)
12. Yanes L, Romero D, Iliescu R, Cucchiarelli VE, Fortepiani LA, Santacruz F, et al. Systemic arterial pressure response to two weeks of tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress. Am J Physiol Regul Integr Comp Physiol 2005; 288:R903-R908. (Pubitemid 40404165)
13. Benter IF, Yousif MH, Dhaunsi GS, Kaur J, Chappell MC, Diz DI. Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am J Nephrol 2008; 28:25-33. (Pubitemid 350126490)
14. Chu Y, Iida S, Lund DD, Weiss RM, DiBona GF, Watanabe Y, et al. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res 2003; 92:461-468. (Pubitemid 36298207)
15. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271:C1424-C1437.
16. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 1998; 32:59-64. (Pubitemid 28324125)
17. Pechanova O, Jendekova L, Vrankova S. Effect of chronic apocynin treatment on nitric oxide and reactive oxygen species production in borderline and spontaneous hypertension. Pharmacol Rep 2009; 61:116-122.
18. Schnackenberg CG, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. Hypertension 1999; 33:424-428. (Pubitemid 29065696)
19. Awolesi MA, Sessa WC, Sumpio BE. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest 1995; 96:1449-1454.
20. Vaziri ND, Wang XQ. cGMP-mediated negative-feedback regulation of endothelial nitric oxide synthase expression by nitric oxide. Hypertension 1999; 34:1237-1241.
21. Grumbach IM, Chen W, Mertens SA, Harrison DG. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription. J Mol Cell Cardiol 2005; 39:595-603. (Pubitemid 41331048)
22. Drummond GR, Cai H, Davis ME, Ramasamy S, Harrison DG. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 2000; 86:347-354. (Pubitemid 30108830)
23. Sousa T, Pinho D, Morato M, Marques-Lopes J, Fernandes E, Afonso J, et al. Role of superoxide and hydrogen peroxide in hypertension induced by an antagonist of adenosine receptors. Eur J Pharmacol 2008; 588:267-276.
24. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126:131-138. (Pubitemid 13203451)
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
26. Endo S, Mori T, Yoneki Y, Nakamichi T, Hosoya T, Ogawa S, et al. Blockade of angiotensin II type-1 receptor increases salt sensitivity in Sprague- Dawley rats. Hypertens Res 2009; 32:513-519.
27. Welch WJ, Tojo A, Wilcox CS. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol Renal Physiol 2000; 278:F769-776. (Pubitemid 30351078)
28. Zhan CD, Sindhu RK, Pang J, Ehdaie A, Vaziri ND. Superoxide dismutase, catalase and glutathione peroxidase in the spontaneously hypertensive rat kidney: effect of antioxidant-rich diet. J Hypertens 2004; 22:2025-2033. (Pubitemid 39336686)
29. Chen X, Patel K, Connors SG, Mendonca M, Welch WJ, Wilcox CS. Acute antihypertensive action of tempol in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2007; 293:H3246-H3253. (Pubitemid 350230863)
30. Peixoto EB, Pessoa BS, Biswas SK, Lopes de Faria JB. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. Am J Nephrol 2009; 29:309-318.
31. Baumer AT, Kruger CA, Falkenberg J, Freyhaus HT, Rosen R, Fink K, et al. The NAD(P)H oxidase inhibitor apocynin improves endothelial NO/ superoxide balance and lowers effectively blood pressure in spontaneously hypertensive rats: comparison to calcium channel blockade. Clin Exp Hypertens 2007; 29:287-299. (Pubitemid 47123899)
32. Paliege A, Pasumarthy A, Mizel D, Yang T, Schnermann J, Bachmann S. Effect of apocynin treatment on renal expression of COX-2, NOS1, and renin in Wistar-Kyoto and spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2006; 290:R694-R700.
33. Wilcox CS, Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev 2008; 60:418-469.
34. Yoshioka T, Ichikawa I, Fogo A. Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 1991; 2:902-912.
35. Makino A, Skelton MM, Zou AP, Cowley AW Jr. Increased renal medullary H2O2 leads to hypertension. Hypertension 2003; 42:25-30. (Pubitemid 36842232)
36. Jones RD, Morice AH. Hydrogen peroxide: an intracellular signal in the pulmonary circulation: involvement in hypoxic pulmonary vasoconstriction. Pharmacol Ther 2000; 88:153-161. (Pubitemid 32057137)
37. Hatoum OA, Binion DG, Miura H, Telford G, Otterson MF, Gutterman DD. Role of hydrogen peroxide in ACh-induced dilation of human submucosal intestinal microvessels. Am J Physiol Heart Circ Physiol 2005; 288:H48-H54. (Pubitemid 40023827)
38. Cseko C, Bagi Z, Koller A. Biphasic effect of hydrogen peroxide on skeletal muscle arteriolar tone via activation of endothelial and smooth muscle signaling pathways. J Appl Physiol 2004; 97:1130-1137. (Pubitemid 39121443)
39. Gao YJ, Lee RM. Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. Br J Pharmacol 2001; 134:1639-1646. (Pubitemid 34038096)
40. Cai H, McNally JS, Weber M, Harrison DG. Oscillatory shear stress upregulation of endothelial nitric oxide synthase requires intracellular hydrogen peroxide and CaMKII. J Mol Cell Cardiol 2004; 37:121-125. (Pubitemid 38900535)
41. Jin C, Hu C, Polichnowski A, Mori T, Skelton M, Ito S, et al. Effects of renal perfusion pressure on renal medullary hydrogen peroxide and nitric oxide production. Hypertension 2009; 53:1048-1053.
42. Mount PF, Power DA. Nitric oxide in the kidney: functions and regulation of synthesis. Acta Physiol (Oxf) 2006; 187:433-446.
43. Feng MG, Dukacz SA, Kline RL. Selective effect of tempol on renal medullary hemodynamics in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2001; 281:R1420-R1425.